本文へスキップ

相互作用

Bazedoxifene-conjugated estrogens + Dalteparin

重症度: 重大

Bazedoxifene-conjugated estrogens and Dalteparin: major interaction.

最終更新日

医療従事者向け・参照専用。このページは簡潔な要約であり、医学的助言ではなく、公式の添付文書や臨床判断に代わるものではありません。処方・調剤の前に必ず確認してください。

このページの臨床コンテンツは英語でのみ提供されています。

概要

Conjugated estrogens and bazedoxifene both raise the risk of venous thromboembolism, which is exactly what dalteparin is given to prevent or treat. The prothrombotic estrogen effect may undermine anticoagulation, and the combination is generally inappropriate in active or prior VTE.

この相互作用をわかりやすく説明すると

Bazedoxifene-conjugated estrogens and Dalteparin can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Bazedoxifene-conjugated estrogens belongs to Endocrine; Dalteparin belongs to Cardiovascular.

エビデンスレベル: Low

なぜ起こるのか

Estrogen and SERM-related prothrombotic changes (increased clotting factors, reduced antithrombin) counteract anticoagulant effect

対処法

Avoid the estrogen/bazedoxifene combination in patients needing therapeutic anticoagulation for VTE; if prophylactic anticoagulation overlaps, reassess the need for hormone therapy.

薬剤師に尋ねること

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+会員向け

ページ全体を見る

アカウントを作成してPro+トライアルを始めると、Bazedoxifene-conjugated estrogensとDalteparinの臨床対応の詳細なアドバイス、追加の注記、エビデンスの詳細、処方全体を対象とした相互作用チェッカーを利用できます。

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

WebでPro+を7日間無料でお試し。カード登録不要。

よくある質問

Can I take Bazedoxifene-conjugated estrogens with Dalteparin?

MediHelp rates the interaction as major. Bazedoxifene-conjugated estrogens and Dalteparin can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Conjugated estrogens and bazedoxifene both raise the risk of venous thromboembolism, which is exactly what dalteparin is given to prevent or treat. The prothrombotic estrogen effect may undermine anticoagulation, and the combination is generally inappropriate in active or prior VTE.

How serious is the interaction between Bazedoxifene-conjugated estrogens and Dalteparin?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the estrogen/bazedoxifene combination in patients needing therapeutic anticoagulation for VTE; if prophylactic anticoagulation overlaps, reassess the need for hormone therapy.

What other medicines interact with Bazedoxifene-conjugated estrogens?

MediHelp also lists interactions of Bazedoxifene-conjugated estrogens with, for example, Anastrozole, Ospemifene, Antithrombin alfa. The full list is on the Bazedoxifene-conjugated estrogens page.

完全なモノグラフ、用量、相互作用チェッカーはMediHelpアプリで

MediHelpアプリで、完全なリファレンスを開き、複数薬剤の相互作用をチェックし、用量ツールを利用できます。

A–Zで探す · 相互作用

アプリを入手 ログイン